Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Ramón García-Sanz

1-50 of 259 results

View this query on the Wikidata Query Service
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

scientific article published on December 2003
Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple m

scientific article published on 23 August 2010
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma

scientific article
Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms

scientific article published on 02 July 2013
EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations.

scientific article published on 24 August 2012
Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling.

scientific article
International prognostic scoring system for Waldenstrom macroglobulinemia

scientific article published on 5 February 2009
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study

scientific article published on 13 June 2006
International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease

scientific article published on 20 May 2013
Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma.

scientific article published on 20 January 2017
Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia

scientific article published on December 2008
Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936.

scientific article published on 14 December 2006
MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia

scientific article
Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry.

scientific article published on 17 July 2013
Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop

scientific article
Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN).

scientific article published on 4 September 2013
Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma.

scientific article published on 18 July 2007
A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia

scientific article published on 01 February 2000
International Myeloma Working Group recommendations for global myeloma care

scientific article published on 09 October 2013
Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases

scientific article published on December 1, 2001
Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene

scientific article published on 7 December 2009
Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics

scientific article published in February 1999
Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial

scientific article published on 13 August 2012
The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed/refractory multiple myeloma

scientific article published in April 2004
Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value.

scientific article
Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma (short title)

scientific article
Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia

scientific article published on 12 January 2006
Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile

scientific article published on 26 September 2013
The Progression from MGUS to Smoldering Myeloma and Eventually to Multiple Myeloma Involves a Clonal Expansion of Genetically Abnormal Plasma Cells

scientific article published on 16 February 2011
Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial.

scientific article
Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry.

scientific article published in October 2005
Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry.

scientific article
C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma

scientific article published on 07 April 2014
Update on recommendations for assessing response from the Third International Workshop on Waldenstrom's Macroglobulinemia

scientific article
Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia

scientific article published on 18 July 2016
Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication

scientific article published on 25 October 2012
Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus

scientific article
Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia

scientific article
SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status

scientific article published on 08 May 2012
Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma

scientific article
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group

scientific article published on 02 September 2010
BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors

scientific article published on 01 September 1997
Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells

scientific article published on 11 October 2009
Pamidronate induces bone formation in patients with smouldering or indolent myeloma, with no significant anti-tumour effect

scientific article published in July 2002
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.

scientific article published on 8 February 2018
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression

scientific article published on 5 March 2008
Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies.

scientific article
6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis

scientific article published on 01 January 2007
Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance

scientific article published on 6 September 2011
Randomized comparison of dexamethasone combined with melphalan versus melphalan with prednisone in the treatment of elderly patients with multiple myeloma.

scientific article published in October 2004

Paulina is supported by:

About Paulina

Help